Niosomes as Biocompatible Scaffolds for the Multivalent Presentation of Tumor-Associated Antigens (TACAs) to the Immune System
暂无分享,去创建一个
[1] P. Besenius,et al. The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response , 2021, Chemical record.
[2] C. Rosano,et al. Modulation of immune responses using adjuvants to facilitate therapeutic vaccination , 2020, Immunological reviews.
[3] F. Gabel,et al. A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer , 2020, iScience.
[4] C. Alfaro,et al. RETRACTED ARTICLE: Significance of the IL-8 pathway for immunotherapy , 2019, Human vaccines & immunotherapeutics.
[5] A. Becchetti,et al. Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain , 2019, Pharmaceutics.
[6] Laura R. Sadofsky,et al. Characterisation of a New Human Alveolar Macrophage-Like Cell Line (Daisy) , 2019, Lung.
[7] J. Wang,et al. Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid-Dependent Immunodominant Response. , 2019, Chemistry, an Asian journal.
[8] R. Fiammengo,et al. Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage. , 2019, Journal of the American Chemical Society.
[9] M. Najafi,et al. Macrophage polarity in cancer: A review , 2018, Journal of cellular biochemistry.
[10] J. T. Afshari,et al. Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.
[11] F. Marincola,et al. Unleashing endogenous TNF-alpha as a cancer immunotherapeutic , 2018, Journal of Translational Medicine.
[12] S. Lucas,et al. Proton irradiation orchestrates macrophage reprogramming through NFκB signaling , 2018, Cell Death & Disease.
[13] P. Seeberger,et al. Synthesis, Liposomal Formulation, and Immunological Evaluation of a Minimalistic Carbohydrate-α-GalCer Vaccine Candidate. , 2018, Journal of medicinal chemistry.
[14] X. Ye,et al. Carbohydrate‐based vaccines for oncotherapy , 2018, Medicinal research reviews.
[15] S. Mathivanan,et al. Secreted Tumor Antigens – Immune Biomarkers for Diagnosis and Therapy , 2017, Proteomics.
[16] M. Cnop,et al. Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells. , 2017, Atherosclerosis.
[17] D. Passeri,et al. Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studies. , 2016, International journal of pharmaceutics.
[18] C. Foged,et al. Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo , 2016, Innate immunity.
[19] J. Munkley. The Role of Sialyl-Tn in Cancer , 2016, International journal of molecular sciences.
[20] Yifa Zhou,et al. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates. , 2016, Bioorganic & medicinal chemistry.
[21] F. Cañada,et al. Structural Insights into the Binding of Sugar Receptors (Lectins) to a Synthetic Tricyclic Tn Mimetic and Its Glycopeptide Version , 2015 .
[22] M. Raes,et al. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide , 2015, BMC Cancer.
[23] J. Taylor‐Papadimitriou,et al. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL , 2015, PloS one.
[24] L. BenMohamed,et al. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity. , 2014, Angewandte Chemie.
[25] O. Renaudet,et al. Recent progress in antitumoral synthetic vaccines. , 2014, ACS medicinal chemistry letters.
[26] Spencer J. Williams,et al. MCL and Mincle: C-Type Lectin Receptors That Sense Damaged Self and Pathogen-Associated Molecular Patterns , 2014, Front. Immunol..
[27] Y. Kooyk,et al. MGL signaling augments TLR2‐mediated responses for enhanced IL‐10 and TNF‐α secretion , 2013, Journal of leukocyte biology.
[28] G. Zaccai,et al. Change of dynamics of raft-model membrane induced by amyloid-β protein binding , 2013, The European physical journal. E, Soft matter.
[29] J. Panee. Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. , 2012, Cytokine.
[30] P. Vogel,et al. A C-linked disaccharide analogue of Thomsen-Friedenreich epitope induces a strong immune response in mice. , 2012, Chemistry.
[31] Alberto Mantovani,et al. Orchestration of metabolism by macrophages. , 2012, Cell metabolism.
[32] C. Ghelardini,et al. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting. , 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[33] G. P. Kumar,et al. Nonionic surfactant vesicular systems for effective drug delivery—an overview , 2011 .
[34] Yup Kang,et al. Capsaicin attenuates palmitate-induced expression of macrophage inflammatory protein 1 and interleukin 8 by increasing palmitate oxidation and reducing c-Jun activation in THP-1 (human acute monocytic leukemia cell) cells. , 2011, Nutrition research.
[35] J. Mes,et al. Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds. , 2010, Food & function.
[36] Anja Hoffmann-Röder,et al. Synthetische Antitumorvakzine aus Tetanus‐Toxoid‐Konjugaten von MUC1‐Glycopeptiden mit Thomsen‐Friedenreich‐Antigen und dessen fluorsubstituiertem Analogon , 2010 .
[37] Dennis R. Burton,et al. Carbohydrate vaccines: developing sweet solutions to sticky situations? , 2010, Nature Reviews Drug Discovery.
[38] Marc Daigneault,et al. The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages , 2010, PloS one.
[39] X. Yao,et al. Controlled evolution from multilamellar vesicles to hexagonal mesostructures through the addition of 1,3,5-trimethylbenzene. , 2009, Journal of colloid and interface science.
[40] L. Legnani,et al. Cyclic glycopeptidomimetics through a versatile sugar-based scaffold. , 2009, Bioorganic & medicinal chemistry letters.
[41] F. Sánchez-Jiménez,et al. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. , 2009, The international journal of biochemistry & cell biology.
[42] O. Wiklund,et al. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. , 2009, Atherosclerosis.
[43] C. Ohyama. Glycosylation in bladder cancer , 2008, International Journal of Clinical Oncology.
[44] K. K. Mong,et al. Versatile acetylation of carbohydrate substrates with bench-top sulfonic acids and application to one-pot syntheses of peracetylated thioglycosides. , 2008, Carbohydrate research.
[45] J. Zou,et al. Structure transition from hexagonal mesostructured rodlike silica to multilamellar vesicles. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[46] L. Legnani,et al. Synthesis, Conformational Studies, Binding Assessment and Liposome Insertion of a Thioether‐Bridged Mimetic of the Antigen GM3 Ganglioside Lactone , 2007, Chembiochem : a European journal of chemical biology.
[47] G. Zaccai,et al. How soft is a protein? A protein dynamics force constant measured by neutron scattering. , 2000, Science.
[48] J. Taylor‐Papadimitriou,et al. Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: , 1996, The Journal of Biological Chemistry.
[49] H. Paulsen,et al. Synthese von L-Prolin-haltigen O-Glycopeptiden , 1990 .